Does Alora (estradiol) cause side effects?
Alora (estradiol) is a form of estrogen, a female hormone, used to treat symptoms of menopause, to prevent bone fractures (osteoporosis), painful uterine bleeding, vaginal pain, dryness and atrophy associated with menopause. Alora is also prescribed to treat breast cancer, and some cases of prostate cancer.
Estrogens occur in nature in several chemical forms. In women with active menstrual cycles, the ovaries produce between 70 and 500 micrograms of estradiol daily. This is converted to estrone and to a lesser extent estriol.
After menopause, estrone made in the adrenal glands, is the most active circulating estrogen. Estrogens cause growth and development of female sex organs and maintain sex characteristics, including underarm and pubic hair and the shape of body contours and skeleton. Estrogens also increase secretions from the cervix and growth of the inner lining of the uterus (endometrium).
Estrogens reduce LDL-cholesterol ("bad" cholesterol) and increase HDL-cholesterol ("good" cholesterol) concentrations in the blood. Estrogens, when taken alone or in combination with a progestin (progesterone), have been shown to reduce the risk for hip fracture due to osteoporosis by 25%.
Common side effects of Alora include
- break-through bleeding or spotting,
- loss of periods or excessively prolonged periods,
- breast pain,
- breast enlargement, and
- changes in sex drive.
Serious side effects of Alora include
- gallstones,
- hepatitis,
- migraine headaches,
- fluid retention (edema),
- melasma (tan or brown patches) on the forehead, cheeks, or temples that may persist even after the estrogen is stopped;
- increased curvature of the cornea that may cause intolerance to contact lenses,
- blood clots (occasional and dose-related,
- increased risk of endometrial cancer, and
- increased risk of developing breast cancer.
Drug interactions of Alora include cyclosporine, because Alora can inhibit the metabolism of cyclosporine, resulting in increased cyclosporine blood levels. Such increased blood levels can result in kidney and/or liver damage.
- Estrogens appear to increase the risk of liver disease in patients receiving dantrolene through an unknown mechanism.
- Estrogens increase the liver's ability to manufacture clotting factors.
- Because of this, patients receiving warfarin need to be monitored for loss of anticoagulant effect if Alora is added when warfarin is already being taken.
- Rifampin, barbiturates, carbamazepine, griseofulvin, phenytoin, primidone and St. John's wort preparations can all increase the elimination of Alora by enhancing the liver's ability to metabolize it.
- Concurrent use may result in reduction of the beneficial effects of Alora.
- On the other hand, drugs such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, and grapefruit juice can decrease the liver's ability to metabolize and eliminate estrogens and may increase the side effects of Alora.
- Alora may increase the levels and effects of exogenous corticosteroids, ropinirole, tipranavir and medications that contain theophylline.
- Alora may reduce the levels and the effects of anastrozole, aripiprazole, axitinib, hyaluronidase, saxagliptin, somatropin, ibrutinib, and ursodiol.
- Estrogen levels and effects may be decreased by dabrafenib, deferasirox, peginterferon Alfa-2b, P-glycoprotein inducers, tocilizumab and herbs that belong to a class of medications called CYP3A4 inducers.
- Herbs with contents similar to estrogens may increase the side effects of Alora.
- Estrogen levels and effects may be increased by dehydroepiandrosterone, P-glycoprotein inhibitors, nonsteroidal anti-inflammatory drugs called COX-2 inhibitors such as celecoxib and ascorbic acid (vitamin C).
Alora should not be used during pregnancy due to an increased risk of fetal abnormalities.
Estrogens are secreted in milk and cause unpredictable effects in the infant. Alora generally should not be used by women if they are breastfeeding.
What are the important side effects of Alora (estradiol)?
- Among the most common endocrine side effects are:
- break-through bleeding or spotting,
- loss of periods or excessively prolonged periods,
- breast pain,
- breast enlargement, and
- changes in sexuality (increase or decrease in libido).
- Abdominal pain may indicate the development of gallstones or occasionally hepatitis.
- Migraine headaches have been associated with estrogen therapy.
- Estrogens can cause sodium and fluid retention leading to edema.
- Melasma, tan or brown patches, may develop on the forehead, cheeks, or temples. These may persist even after the estrogen is stopped.
- Conjugated estrogens may cause an increase in the curvature of the cornea. Patients with contact lenses may develop intolerance to their lenses.
- Blood clots are an occasional but serious adverse effect and are dose-related. (The higher the dose of estradiol, the more likely blood clots are to form.) Cigarette smokers are at a higher risk for clots, and, therefore, patients requiring estrogen therapy are strongly encouraged to quit smoking.
- Estrogens can increase the risk of endometrial cancer. This risk may be decreased if estrogens are combined with progestin.
- Some people also have a higher chance of developing breast cancer while taking estrogens. Sometimes people who have breast cancer when they are taking estrogens may have increased calcium in the blood. If this happens, the estrogen should be stopped.
Alora (estradiol) side effects list for healthcare professionals
The following serious adverse reactions are discussed elsewhere in the labeling:
- Cardiovascular Disorders
- Malignant Neoplasms
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reactions rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Adverse reactions for Alora 0.025 mg/day, 0.05 mg/day, and 0.075 mg/day transdermal systems versus placebo, each applied twice weekly, were evaluated in a 2-year randomized, parallel-group, double-blind, double-dummy, placebo-controlled multicenter trial for the prevention of osteoporosis in 355 hysterectomized postmenopausal women. Adverse reactions with an incidence greater than 2% and greater than placebo, are shown in Table 1
Table 1 : Adverse Reactions for Alora 0.025 mg/day, 0.05 mg/day, and 0.075 mg/day Transdermal Systems, Occurring at Greater than 2% (and greater than Placebo) in a Two-Year Prevention of Osteoporosis Trial (data are expressed as N and (%) of treatment group).
Body System | Placebo (N = 87) | Alora 0.025 mg/day (N = 89) | Alora 0.05 mg/day (N = 90) | Alora 0.075 mg/day (N = 89) |
Preferred Term | n (%) | n (%) | n (%) | n (%) |
Body As A Whole | ||||
Asthenia | 4 (4.6) | 7 (7.9) | -- | -- |
Cyst | 3 (3.4) | -- | 6 (6.7) | -- |
Infection Fungal | 1 (11) | 3 (3.4) | 9 (10) | 4 (4.5) |
Pain Abdominal | 4 (4.6) | 7 (7.9) | 5 (5.6) | -- |
Pain Back | 5 (5.7) | -- | -- | 7 (7.9) |
Cardiovascular Hypertension Migraine | 3 (3.4) 2 (2.3) | 6 (6.7) | -- | 6 (6.7) |
Digestive | ||||
Dyspepsia | 1 (11) | 8 (9) | 4 (4.4) | 3 (3.4) |
Gastroenteritis | 2 (2.3) | 3 (3.4) | 4 (4.4) | 3 (3.4) |
Nausea | 3 (3.4) | 6 (6.7) | 5 (5.6) | -- |
Nervous | ||||
Dizziness | 0 (0) | -- | 7 (7.8) | 4 (4.5) |
Skin | ||||
Hirsutism | 0 (0) | 2 (2.2) | 2 (2.2) | 4 (4.5) |
Pruritus | 4 (4.6) | -- | -- | 6 (6.7) |
Rash | 5 (5.7) | 6 (6.7) | 8 (8.9) | -- |
Urogenital | ||||
Breast Enlargement | 3 (3.4) | -- | -- | 6 (6.7) |
Leukorrhea | 1 (11) | 3 (3.4) | 2 (2.2) | 4 (4.5) |
Pain Breast | 7 (8) | 13 (14.6) | 16 (17.8) | 31 (34.8) |
--represents exclusion of data that was less than 2% or less than placebo. |
Postmarketing Experience
The following adverse reactions have been identified during post-approval use of Alora. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Genitourinary system: Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow, breakthrough bleeding, spotting, dysmenorrhea, metrorrhagia, menorrhagia, amenorrhea, vaginitis, including vaginal candidiasis, vulvovaginal dryness, vulvovaginal pruritus, endometrial cancer.
- Breast: Pain, tenderness, enlargement, swelling, breast cancer, nipple pain, galactorrhea.
- Cardiovascular: Hot flushes, palpitations, tachycardia, increase in blood pressure, deep venous thrombosis, pulmonary embolism.
- Gastrointestinal: Nausea, vomiting, abdominal pain, abdominal distention, flatulence, diarrhea, gallbladder disease, pancreatitis.
- Skin: Rash, pruritus, alopecia, erythema nodosum, hemorrhagic eruption, hyperhidrosis, hirsutism, application site reaction.
- Eyes: Blurred vision, visual impairment.
- Central nervous system: Headache, migraine, dizziness, insomnia, anxiety, mental depression, nervousness, mood swings, irritability, hypoaesthesia, paresthesia, somnolence, loss of libido.
- Miscellaneous: Increase or decrease in weight, reduced carbohydrate tolerance, arthalgias, back pain, increased triglycerides, increased cholesterol, exacerbation of asthma, vertigo.
What drugs interact with Alora (estradiol)?
- In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4). Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism.
- Inducers of CYP3A4 such as St. John's Wort preparations (Hypericum perforatum), phenobarbital, phenytoin, carbamazepine, rifampin and dexamethasone may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile.
- Inhibitors of CYP3A4 such as cimetidine, erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may increase plasma concentrations of estrogens and may result in adverse reactions.
Summary
Alora (estradiol) is a form of estrogen, a female hormone, used to treat symptoms of menopause, to prevent bone fractures (osteoporosis), painful uterine bleeding, vaginal pain, dryness and atrophy associated with menopause. Alora is also prescribed to treat breast cancer, and some cases of prostate cancer. Common side effects of Alora include break-through bleeding or spotting, loss of periods or excessively prolonged periods, breast pain, breast enlargement, and changes in sex drive. Alora should not be used during pregnancy due to an increased risk of fetal abnormalities. Estrogens are secreted in milk and cause unpredictable effects in the infant. Alora generally should not be used by women if they are breastfeeding.
Multimedia: Slideshows, Images & Quizzes
-
Menopause & Perimenopause: Symptoms, Signs
What is menopause? What are the signs of menopause? What age does menopause start? Learn about menopause and perimenopause...
-
Menopause Quiz: Symptoms & Signs
The Menopause Quiz challenges your knowledge about the time in a woman’s life when menstruation ceases. Menopause can bring many...
-
9 Signs of Perimenopause
Perimenopause occurs before menopause as estrogen levels begin to change. This can cause menopause like symptoms such as hot...
-
Women's Health: 10 Tips to Ease Menopause Symptoms
What happens during menopause? At what age do menopause symptoms start? Women in their 40s or 50s may begin to have hot flashes,...
Related Disease Conditions
-
Menopause
Menopause is the time in a woman's life when menstrual periods permanently stop, also called the "change of life." Menopause symptoms and signs include hot flashes, night sweats, irregular vaginal bleeding, vaginal dryness, painful intercourse, urinary incontinence, weight gain, and emotional symptoms such as mood swings. Treatment of menopausal symptoms varies and should be discussed with your physician.
-
Sex and Menopause
-
Perimenopause
Perimenopause is the time in a woman's life when she is approaching menopause. During this time a woman starts to develop symptoms of declining estrogen levels that may include mood swings, painful sex, night sweats, hot flashes, and weight gain. Every adult woman eventually will experience perimenopause.
-
Premature Menopause
Premature menopause is when menopause occurs in a woman before the age of 40. Causes of premature menopause include premature ovarian failure, treatments for cancer and other conditions, surgical removal of the ovaries, chronic diseases of the pituitary or thyroid gland, or psychiatric disorders. Treatment is directed at menopausal symptoms.
-
What Are the 40 Symptoms of Menopause?
Menopause is the end of the reproductive era of a woman's life that is characterized by drastic changes in her emotional and physical aspects. Studies have identified around 40 signs and symptoms of menopause, but not every woman gets all of them.
-
Male Menopause
Male menopause refers to the decline in testosterone production in men. As men age, they often experience many of the same symptoms that women experience in menopause. Testosterone replacement therapy may relieve some of these symptoms.
-
Sex and Menopause
Menopause is often associated with a change in sexual functioning. Loss of estrogen, bladder control issues, anxiety, stress, health concerns, medications, and sleep disturbances often result in a decrease in libido. Though there are currently no good drugs for treating sexual problems in women, there are ways to increase intimacy with a partner and treat vaginal dryness.
-
15 Things Women Should Know About Menopause
Menopause is a phase in a woman's life that challenges her physically and emotionally. Many women deal with menopause without any medical treatments, whereas some women with severe symptoms require therapies.
-
Sexual Side Effects of Menopause
Menopause marks the end of the reproductive era in a woman's life. Some women view it positively as periods no longer trouble them and there is no chance of getting pregnant even with unprotected sex. However, as estrogen and testosterone levels take a plunge during menopause, some women experience the sexual side effects of menopause.
Treatment & Diagnosis
- Menopause
- Menopause: Making it the Best Years of Your Life
- Menopause and Perimenopause, A Woman's Guide to
- Male Menopause
- Perimenopause
- Menopause: The Men's Guide to Understanding It
- Menopause: Super Nutrition for Menopause
- Menopause: A New Perspective
- Hormone Therapy After Menopause -- Susan Love, MD
- Menopause: Taking Charge
- Menopause Made Easy with Carolle Jean-Murat
- Menopause: Change of Life, Change of Diet
- Menopause FAQs
- Thyroid Disease and Menopause
- The Women's Health Initiative in Perspective: The Last Straw for Estrogen Therapy?
- Menopause: Home Menopause Test Kits, Are They Worth It?
- Hot Flashes: Anxiety Worsens Hot Flashes
- Can Menopause Cause High Cholesterol?
- How Is Menopause Diagnosed After a Hysterectomy?
- How Does Menopause Affect Polycystic Ovarian Syndrome (PCOS)?
- Does Vaginal Moisture Change During Perimenopause?
- Do Soy Isoflavones Treat Menopause Hot Flashes?
- Can You Go Through Menopause at 40?
- Does Perimenopause Cause Mood Swings?
- Does Menopause Cause Pain During Sex?
- Does Menopause Affect Memory?
- Are Night Sweats a Sign of Menopause?
- Can Soy Help Menopause Symptoms?
- Do I Need Birth Control After Menopause?
- Does Menopause Cause High Blood Pressure?
- Do You Get More UTIs During Menopause?
- Can You Still Get Menopause After Hysterectomy?
- Do All Women Get Menopause?
- Male Menopause
- Menopause: 10 Questions To Ask Your Doctor
- Menopause Symptoms
- Ask the Experts - Menopause
- Menopause: Change of Life, Change of Diet
Medications & Supplements

Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.